美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA210790"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
65162-437-03 65162-437 HUMAN PRESCRIPTION DRUG Levomilnacipran Levomilnacipran CAPSULE, EXTENDED RELEASE ORAL 20190204 N/A ANDA ANDA210790 Amneal Pharmaceuticals LLC LEVOMILNACIPRAN HYDROCHLORIDE 80 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-437-03)
65162-960-03 65162-960 HUMAN PRESCRIPTION DRUG Levomilnacipran Levomilnacipran CAPSULE, EXTENDED RELEASE ORAL 20190204 N/A ANDA ANDA210790 Amneal Pharmaceuticals LLC LEVOMILNACIPRAN HYDROCHLORIDE 40 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-960-03)
65162-455-03 65162-455 HUMAN PRESCRIPTION DRUG Levomilnacipran Levomilnacipran CAPSULE, EXTENDED RELEASE ORAL 20190204 N/A ANDA ANDA210790 Amneal Pharmaceuticals LLC LEVOMILNACIPRAN HYDROCHLORIDE 120 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-455-03)
65162-411-03 65162-411 HUMAN PRESCRIPTION DRUG Levomilnacipran Levomilnacipran CAPSULE, EXTENDED RELEASE ORAL 20190204 N/A ANDA ANDA210790 Amneal Pharmaceuticals LLC LEVOMILNACIPRAN HYDROCHLORIDE 20 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-411-03)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase